search
Back to results

Depression in Chronic Airways Diseases

Primary Purpose

Chronic Lung Disease

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
hospital anxiety and depression scale
Sponsored by
Assiut University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Chronic Lung Disease

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Chronic airways diseases as chronic obstructive pulmonary disease, bronchial asthma, bronchiectasis

Exclusion Criteria:

  • Diabetes Mellitus and Hypertension.
  • Cardiac diseases.
  • Chronic renal and liver diseases.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Other

    Arm Label

    chronic lung diseases

    Arm Description

    bronchiectasis , bronchial asthma and chronic obstructive pulmonary disease assess anxiety and depression by hospital anxiety and depression scale

    Outcomes

    Primary Outcome Measures

    compare anxiety and depression in different forms of chronic lung diseases
    by hospital anxiety and depression scale

    Secondary Outcome Measures

    Full Information

    First Posted
    June 6, 2017
    Last Updated
    January 8, 2018
    Sponsor
    Assiut University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03180164
    Brief Title
    Depression in Chronic Airways Diseases
    Official Title
    Anxiety and Depression in Chronic Airways Diseases
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    January 2018
    Overall Recruitment Status
    Unknown status
    Study Start Date
    October 2018 (Anticipated)
    Primary Completion Date
    October 2019 (Anticipated)
    Study Completion Date
    October 2019 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Assiut University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Chronic airways diseases involve alterations in the person's social roles, relationships and self-perception so demands continual psychological adjustment . Also Kunik studied patients with chronic breathing disorders for depression and anxiety and found that 65% of patients were positive for depression and anxiety. Shackell found that patients' anxiety and fears of breathlessness and dying extended into the night and were aggravated by feelings of isolation and frustration. One patient reported that they often thought 'am I going to see the next morning?'
    Detailed Description
    This fear and sense of helplessness can lead to panic and evidence suggests that patients with chronic breathlessness often call for emergency assistance during the night According to GOLD report 2017, anxiety and depression in chronic obstructive pulmonary disease patients are both associated with poor prognosis. Much of the evidence explored so far relates to chronic obstructive pulmonary disease. While other chronic lung diseases have received less attention In addition to, several studies have been found relationship between asthma and psychological disturbance .One review of literature describes an increased prevalence of psychological co-morbidity in asthmatic adults and another research suggests that anxiety and depression are more common in patients with moderate to severe asthma than in the general population Gift. found significantly greater self-reported depression scores among patients with chronic obstructive pulmonary disease receiving prednisone compared to patients not receiving any steroids. Interestingly, the psychiatric sequel of steroid treatment are often sudden in onset and appear to generally occur within 2 weeks after steroid introduction

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Chronic Lung Disease

    7. Study Design

    Primary Purpose
    Screening
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    1 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    chronic lung diseases
    Arm Type
    Other
    Arm Description
    bronchiectasis , bronchial asthma and chronic obstructive pulmonary disease assess anxiety and depression by hospital anxiety and depression scale
    Intervention Type
    Other
    Intervention Name(s)
    hospital anxiety and depression scale
    Intervention Description
    self-assessment scale has been developed and found to be a reliable instrument for detecting states of depression and anxiety in the setting of an hospital medical outpatient clinic
    Primary Outcome Measure Information:
    Title
    compare anxiety and depression in different forms of chronic lung diseases
    Description
    by hospital anxiety and depression scale
    Time Frame
    10 minutes

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    60 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Chronic airways diseases as chronic obstructive pulmonary disease, bronchial asthma, bronchiectasis Exclusion Criteria: Diabetes Mellitus and Hypertension. Cardiac diseases. Chronic renal and liver diseases.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Maha Ahmed El-Kholy
    Phone
    00201096956205
    Email
    maha_elkholy@gmail.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    Samiaa Hamdy Sadek
    Phone
    00201006769597
    Email
    samiaa_sadek@yahoo.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Reham Mohamed El-Morshedy
    Organizational Affiliation
    Assiut University
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Depression in Chronic Airways Diseases

    We'll reach out to this number within 24 hrs